Search

everythinglearnresearchcommunity

for

Search:↓

Researchers found a specific T cell receptor linked to severe drug reactions like Stevens-Johnson syndrome when patients take carbamazepine.

Mouse skin has special cells in the epidermis that decrease with age and are linked to keratinocyte stem cells.

miR-200c-3p could help diagnose and treat alopecia areata.

CRISPR/Cas9 and prime editing can potentially fix skin disorder genes safely and effectively.

Activating Notch signaling can kill basal cell carcinoma cells.

Enhancing immune response can improve cancer treatment effectiveness.

ODC expression in mouse skin and tumors is varied and can be inhibited by retinoic acid or cycloheximide.

Aire mutation reduces alopecia areata, while Notch4 mutation prevents it in mice.

Finasteride increases CD8+ T cells in BPH tissues.

iNKT cells can help prevent and treat alopecia areata by promoting hair regrowth.

Understanding how Regulatory T Cells work could help create treatments for certain skin diseases and cancers.

The gene therapy showed significant wound healing and was safe for treating severe RDEB.

Severe alopecia areata involves higher levels of certain immune cells, which can be normalized with betamethasone.

Blocking LFA-1 prevents hair loss in mice.

Basal cell carcinomas and squamous cell carcinomas have different gene activity patterns, suggesting unique treatment approaches.

IFN-γ and IL-2 are important for T cell activation in hair loss in mice.

CEP135 may predict cancer outcomes, and targeting PLK1 could help treat certain sarcomas.

Memory regulatory T cells need IL-7, not IL-2, to stay in peripheral tissues.

A specific type of immune cells, called CD301b-expressing macrophages, are crucial for skin repair processes.

Both induced and spontaneous AA lymphocytes can cause alopecia areata in mice.

CD8+ T cells attack hair follicle stem cells, causing scarring and hair loss.

The conclusion is that CD90 is not a specific marker for fibroblast subtypes and better methods are needed to identify them.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

Thymoma with alopecia areata may be linked to abnormal immune cells.

People with atopic dermatitis have more CD4+ T cells that respond to a certain bacterial lipid, which may play a role in the skin condition's inflammation.

Ifidancitinib, a JAK inhibitor, effectively regrows hair in mice with alopecia by tiring out harmful T cells.

Keratinocytes can reduce the survival of certain melanoma cells, suggesting new therapy paths.

The study identified key immune cell differences between mild and severe alopecia areata.